Respiratory syncytial virus genetic and antigenic diversity
- PMID: 10627488
- PMCID: PMC88930
- DOI: 10.1128/CMR.13.1.1
Respiratory syncytial virus genetic and antigenic diversity
Abstract
Respiratory syncytial virus (RSV) is a major cause of viral lower respiratory tract infections among infants and young children in both developing and developed countries. There are two major antigenic groups of RSV, A and B, and additional antigenic variability occurs within the groups. The most extensive antigenic and genetic diversity is found in the attachment glycoprotein, G. During individual epidemic periods, viruses of both antigenic groups may cocirculate or viruses of one group may predominate. When there are consecutive annual epidemics in which the same group predominates, the dominant viruses are genetically different from year to year. The antigenic differences that occur among these viruses may contribute to the ability of RSV to establish reinfections throughout life. The differences between the two groups have led to vaccine development strategies that should provide protection against both antigenic groups. The ability to discern intergroup and intragroup differences has increased the power of epidemiologic investigations of RSV. Future studies should expand our understanding of the molecular evolution of RSV and continue to contribute to the process of vaccine development.
Figures
Similar articles
-
Epidemiology. Does viral diversity matter?Science. 2009 Jul 17;325(5938):274-5. doi: 10.1126/science.1177475. Science. 2009. PMID: 19608903 No abstract available.
-
[Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus].Bing Du Xue Bao. 2015 Mar;31(2):201-6. Bing Du Xue Bao. 2015. PMID: 26164949 Review. Chinese.
-
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.J Virol. 1994 Sep;68(9):5448-59. doi: 10.1128/JVI.68.9.5448-5459.1994. J Virol. 1994. PMID: 8057427 Free PMC article.
-
Mucosal vaccines against respiratory syncytial virus.Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Curr Opin Virol. 2014. PMID: 24794644 Free PMC article. Review.
-
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.Virology. 2000 Mar 30;269(1):54-65. doi: 10.1006/viro.2000.0186. Virology. 2000. PMID: 10725198
Cited by
-
ON-1 and BA-IX Are the Dominant Sub-Genotypes of Human Orthopneumovirus A&B in Riyadh, Saudi Arabia.Genes (Basel). 2022 Dec 5;13(12):2288. doi: 10.3390/genes13122288. Genes (Basel). 2022. PMID: 36553555 Free PMC article.
-
Global Seasonal Activities of Respiratory Syncytial Virus Before the Coronavirus Disease 2019 Pandemic: A Systematic Review.Open Forum Infect Dis. 2024 Apr 25;11(5):ofae238. doi: 10.1093/ofid/ofae238. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38770210 Free PMC article. Review.
-
Molecular Diversity of Human Respiratory Syncytial Virus before and during the COVID-19 Pandemic in Two Neighboring Japanese Cities.Microbiol Spectr. 2023 Aug 17;11(4):e0260622. doi: 10.1128/spectrum.02606-22. Epub 2023 Jul 6. Microbiol Spectr. 2023. PMID: 37409937 Free PMC article.
-
Characterization of an orally available respiratory syncytial virus L protein polymerase inhibitor DZ7487.Am J Transl Res. 2023 Mar 15;15(3):1680-1692. eCollection 2023. Am J Transl Res. 2023. PMID: 37056816 Free PMC article.
-
Recent sequence variation in probe binding site affected detection of respiratory syncytial virus group B by real-time RT-PCR.J Clin Virol. 2017 Mar;88:21-25. doi: 10.1016/j.jcv.2016.12.011. Epub 2017 Jan 5. J Clin Virol. 2017. PMID: 28107671 Free PMC article.
References
-
- Akerlind B, Norrby E. Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol. 1986;19:241–274. - PubMed
-
- Akerlind B, Norrby E, Orvell C, Mufson M A. Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol. 1988;69:2145–2154. - PubMed
-
- Akerlind-Stopner B, Utter G, Norrby E, Mufson M A. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response. J Med Virol. 1995;47:120–125. - PubMed
-
- American Academy of Pediatrics Committee on Infectious Diseases. 1997 Redbook. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village: AAP; 1997.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical